6 completed, 1 unknown. 7 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 6, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow EuBiologics Co.,Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase III Study of COVID-19 Vaccine EuCorVac-19 in Healthy Adults EuCorVac-19, ChAdOx1 nCoV-19 - COVID-19 | Phase 3 | Completed | EuBiologics Co.,Ltd | 2600 | 2022-10-01 | 2024-06-17 |
| A Phase III of COVID-19 Vaccine EuCorVac-19 in Healthy Adults Aged 18 Years and Older EuCorVac-19, ChAdOx1 nCoV-19 - COVID-19 | Phase 3 | Completed | EuBiologics Co.,Ltd | 2852 | 2022-07-11 | 2025-01-07 |
| Immune Non-Inferiority, Safety and Lot-to-Lot Consistency of Oral Cholera Vaccine-Simplified Compared to Shanchol™ Oral Cholera Vaccine Simplified (OCV-S), Shanchol™ - Cholera | Phase 3 | Completed | International Vaccine Institute | 2530 | 2021-10-06 | 2023-06-22 |
| Non-inferiority and Safety Study of EuTCV Compared to Typbar-TCV in Healthy 6 Months-45 Years Aged Participants EuTCV (Vi-CRM Typhoid conjugate vaccine), Typbar-TCV - Typhoid Fever | Phase 2 / Phase 3 | Completed | EuBiologics Co.,Ltd | 444 | 2020-09-07 | 2021-10-07 |
| Efficacy and Safety of Botulinum Toxin at Moderate to Severe Glabellar Lines ATGC-100 100U, Botox 100U - Glabellar Frown Lines | Phase 3 | Completed | EuBiologics Co.,Ltd | 290 | 2020-06-29 | 2022-04-04 |
| Safety and Immunogenicity of a New Formulation of Euvichol® Test Oral Cholera Vaccine, Euvichol® - Cholera | Phase 3 | Unknown | International Vaccine Institute | 442 | 2016-03-01 | 2015-12-17 |
| To Evaluate the Efficacy (Immunogenicity) and Safety of Euvichol in Healthy Adults and Children Euvichol, Shanchol - Prevention Harmful Effects | Phase 3 | Completed | EuBiologics Co.,Ltd | 3632 | 2014-05-01 | 2014-12-08 |
COVID-19 (2) · Cholera (2) · Typhoid Fever (1)
ChAdOx1 nCoV-19 (2) · shanchol (2) · Botulinum Toxins, Type A (1) · Cholera Vaccines (1)
Philippines (3) · Democratic Republic of the Congo (1) · Nepal (1) · South Korea (1)
Julia Lynch, MD (1) · Laura Digilio, MD (1) · Roberto A. Espos, MD (1)
PMID 29895500, PMID 36774331, PMID 38614631, PMID 39318203, PMID 40872863